|
Market Closed -
OTC Markets
07:01:55 26/05/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.3800 USD | -28.30% |
|
-15.56% | -15.56% |
| 06/04 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 12/11 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 21.75L 18.71L 17.56L 16.07L 29.99L 21Cr 30.22L 2.08Cr 80.9L 11Cr 81.67L 79.89L 34Cr | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.35Cr 1.16Cr 1.09Cr 99.59L 1.86Cr 127.45Cr 1.87Cr 13Cr 5.01Cr 65Cr 5.06Cr 4.95Cr 209.76Cr | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Cyanotech Corporation
| 1 day | -28.30% | ||
| 1 week | -15.56% | ||
| Current month | -9.52% | ||
| 1 month | -28.27% | ||
| 3 months | -13.64% | ||
| 6 months | -11.63% | ||
| Current year | -15.56% |
| 1 week | 0.38 |  | 0.53 |
| 1 month | 0.35 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.23 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.30% | -15.56% | +35.71% | -41.54% | 36.97L | |
| -0.04% | -1.40% | +57.16% | +108.15% | 1,03400Cr | |
| +1.17% | +4.76% | +56.42% | +73.50% | 66TCr | |
| -0.58% | +0.80% | +22.82% | +75.58% | 46TCr | |
| +2.09% | -2.06% | +32.28% | +37.41% | 34TCr | |
| 0.00% | +5.36% | +27.40% | +46.97% | 31TCr | |
| +1.42% | +0.26% | -0.52% | +13.51% | 25TCr | |
| +0.29% | +1.63% | +56.46% | +73.00% | 24TCr | |
| -0.03% | +2.13% | -17.30% | -53.65% | 21TCr | |
| +1.08% | +1.59% | +33.83% | +97.29% | 19TCr | |
| Average | -2.35% | +0.30% | +30.43% | +43.02% | 36.93TCr | |
| Weighted average by Cap. | +0.33% | +0.40% | +38.63% | +67.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.31Cr 1.99Cr 1.86Cr 1.7Cr 3.18Cr 218.09Cr 3.21Cr 22Cr 8.58Cr 111.45Cr 8.66Cr 8.47Cr 358.95Cr | 2.42Cr 2.08Cr 1.96Cr 1.79Cr 3.34Cr 228.91Cr 3.37Cr 23Cr 9.01Cr 116.98Cr 9.09Cr 8.89Cr 376.75Cr |
| Net income | -52.67L -45.32L -42.53L -38.91L -72.62L -50Cr -73.2L -5.03Cr -1.96Cr -25Cr -1.98Cr -1.93Cr -82Cr | -32.03L -27.56L -25.86L -23.66L -44.16L -30Cr -44.51L -3.06Cr -1.19Cr -15Cr -1.2Cr -1.18Cr -50Cr |
| Net Debt | 1.02Cr 87.73L 82.33L 75.33L 1.41Cr 96Cr 1.42Cr 9.74Cr 3.79Cr 49Cr 3.83Cr 3.75Cr 158.65Cr | 1.13Cr 97.29L 91.29L 83.53L 1.56Cr 106.89Cr 1.57Cr 11Cr 4.21Cr 55Cr 4.25Cr 4.15Cr 175.92Cr |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $0.5300 | +3.92% | 11,606 |
| 02/26/02 | $0.5100 | +21.43% | 1,220 |
| 31/26/31 | $0.4200 | -16.00% | 943 |
| 28/26/28 | $0.5000 | +11.11% | 50,500 |
| 26/26/26 | $0.4500 | -.--% | 500 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
